Showing results (151-160 of 686) with videos related to

Sort By:
Pageof 69
American Journal of Preventive Cardiology|February 20, 2024
Emerging therapies for MASLD and their impact on plasma lipidsMadison Nguyen, Amon Asgharpour, Dave L Dixon, et al.
Gastroenterology|August 5, 2023
AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert ReviewJulia J Wattacheril, Manal F Abdelmalek, Joseph K Lim, et al.
Therapeutic Drug Monitoring|August 1, 1996
Use of hepatic lidocaine metabolism to monitor patients with chronic liver diseaseM L Shiffman, V A Luketic, A J Sanyal, et al.
Gastroenterology|August 1, 1991
Premicellar taurocholate enhances ferrous iron uptake from all regions of rat small intestineA J Sanyal, M L Shiffmann, J I Hirsch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2025
Experimental Models to Investigate PNPLA3 in Liver SteatosisAlireza Ramandi, Anna-Mae Diehl, Arun J Sanyal, et al.
JHEP Reports : Innovation in Hepatology|April 16, 2026
Disease-driven loss of inactive HSD17B13 isoforms enhances enzymatic output in MASH and counters protective rs72613567:TA variantJohn Min, Mulugeta Seneshaw, Faridoddin Mirshahi, et al.
JHEP Reports : Innovation in Hepatology|February 23, 2023
Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLDJennifer Linge, Patrik Nasr, Arun J Sanyal, et al.
International Journal of Hygiene and Environmental Health|March 16, 2013
Multiple classes of environmental chemicals are associated with liver disease: NHANES 2003-2004Krista L Yorita Christensen, Caroline K Carrico, Arun J Sanyal, et al.
Diabetes & Metabolism|September 20, 2021
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial designPierpaolo Pellicori, Muthiah Vaduganathan, João Pedro Ferreira, et al.
Gastro Hep Advances|February 16, 2026
Lower Health Literacy Is Associated With Greater Severity of Metabolic Dysfunction and Steatotic Liver DiseaseAlana Saddic, Jessica N Mittler, Ekaterina Smirnova, et al.
Pageof 69